Ann Hynes
Stock Analyst at Mizuho
(4.21)
# 476
Out of 5,182 analysts
290
Total ratings
61.29%
Success rate
10.6%
Average return
Main Sectors:
Stocks Rated by Ann Hynes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BTSG BrightSpring Health Services | Maintains: Outperform | $50 → $52 | $48.57 | +7.06% | 5 | Mar 18, 2026 | |
| THC Tenet Healthcare | Maintains: Outperform | $235 → $265 | $185.53 | +42.83% | 17 | Mar 12, 2026 | |
| MOH Molina Healthcare | Maintains: Outperform | $220 → $180 | $179.22 | +0.44% | 10 | Mar 12, 2026 | |
| ELV Elevance Health | Maintains: Outperform | $413 → $350 | $356.13 | -1.72% | 7 | Mar 11, 2026 | |
| CNC Centene | Maintains: Neutral | $47 → $41 | $43.50 | -5.75% | 10 | Mar 11, 2026 | |
| SGRY Surgery Partners | Maintains: Outperform | $19 → $17 | $14.54 | +16.92% | 5 | Mar 5, 2026 | |
| HCA HCA Healthcare | Maintains: Outperform | $540 → $585 | $445.77 | +31.23% | 24 | Feb 25, 2026 | |
| CRL Charles River Laboratories International | Maintains: Neutral | $215 → $175 | $171.23 | +2.20% | 5 | Feb 20, 2026 | |
| DGX Quest Diagnostics | Maintains: Outperform | $210 → $235 | $196.63 | +19.51% | 17 | Feb 12, 2026 | |
| UNH UnitedHealth Group | Maintains: Outperform | $430 → $350 | $354.69 | -1.32% | 22 | Feb 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $11 → $13 | $10.60 | +22.64% | 6 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $20 → $12 | $10.04 | +19.52% | 4 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $22 → $17 | $28.15 | -39.61% | 13 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $88 → $95 | $78.36 | +21.24% | 12 | Dec 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $575 → $655 | $421.37 | +55.45% | 5 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $285 → $320 | $263.43 | +21.47% | 16 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $300 → $345 | $223.62 | +54.28% | 9 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $190 → $225 | $163.84 | +37.33% | 13 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $173 → $225 | $103.21 | +118.00% | 16 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $13 → $15 | $23.39 | -35.87% | 11 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $110 → $120 | $202.34 | -40.69% | 8 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $28 | $22.67 | +23.51% | 1 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $93 → $95 | $100.92 | -5.87% | 8 | Apr 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $370 → $385 | $282.58 | +36.24% | 10 | Mar 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $175 → $200 | $179.51 | +11.41% | 15 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $242 → $268 | $1.11 | +24,044.14% | 1 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $450 → $505 | $828.32 | -39.03% | 19 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $57 | $0.90 | +6,241.08% | 1 | Sep 21, 2017 |
BrightSpring Health Services
Mar 18, 2026
Maintains: Outperform
Price Target: $50 → $52
Current: $48.57
Upside: +7.06%
Tenet Healthcare
Mar 12, 2026
Maintains: Outperform
Price Target: $235 → $265
Current: $185.53
Upside: +42.83%
Molina Healthcare
Mar 12, 2026
Maintains: Outperform
Price Target: $220 → $180
Current: $179.22
Upside: +0.44%
Elevance Health
Mar 11, 2026
Maintains: Outperform
Price Target: $413 → $350
Current: $356.13
Upside: -1.72%
Centene
Mar 11, 2026
Maintains: Neutral
Price Target: $47 → $41
Current: $43.50
Upside: -5.75%
Surgery Partners
Mar 5, 2026
Maintains: Outperform
Price Target: $19 → $17
Current: $14.54
Upside: +16.92%
HCA Healthcare
Feb 25, 2026
Maintains: Outperform
Price Target: $540 → $585
Current: $445.77
Upside: +31.23%
Charles River Laboratories International
Feb 20, 2026
Maintains: Neutral
Price Target: $215 → $175
Current: $171.23
Upside: +2.20%
Quest Diagnostics
Feb 12, 2026
Maintains: Outperform
Price Target: $210 → $235
Current: $196.63
Upside: +19.51%
UnitedHealth Group
Feb 5, 2026
Maintains: Outperform
Price Target: $430 → $350
Current: $354.69
Upside: -1.32%
Dec 18, 2025
Maintains: Neutral
Price Target: $11 → $13
Current: $10.60
Upside: +22.64%
Dec 18, 2025
Maintains: Outperform
Price Target: $20 → $12
Current: $10.04
Upside: +19.52%
Dec 18, 2025
Maintains: Neutral
Price Target: $22 → $17
Current: $28.15
Upside: -39.61%
Dec 10, 2025
Maintains: Outperform
Price Target: $88 → $95
Current: $78.36
Upside: +21.24%
Oct 24, 2025
Maintains: Outperform
Price Target: $575 → $655
Current: $421.37
Upside: +55.45%
Oct 17, 2025
Maintains: Outperform
Price Target: $285 → $320
Current: $263.43
Upside: +21.47%
Oct 9, 2025
Maintains: Outperform
Price Target: $300 → $345
Current: $223.62
Upside: +54.28%
Jul 25, 2025
Maintains: Outperform
Price Target: $190 → $225
Current: $163.84
Upside: +37.33%
Jul 25, 2025
Maintains: Outperform
Price Target: $173 → $225
Current: $103.21
Upside: +118.00%
Nov 19, 2024
Maintains: Neutral
Price Target: $13 → $15
Current: $23.39
Upside: -35.87%
Nov 4, 2024
Maintains: Neutral
Price Target: $110 → $120
Current: $202.34
Upside: -40.69%
Aug 19, 2024
Initiates: Outperform
Price Target: $28
Current: $22.67
Upside: +23.51%
Apr 25, 2024
Maintains: Buy
Price Target: $93 → $95
Current: $100.92
Upside: -5.87%
Mar 8, 2024
Maintains: Buy
Price Target: $370 → $385
Current: $282.58
Upside: +36.24%
Mar 6, 2024
Maintains: Buy
Price Target: $175 → $200
Current: $179.51
Upside: +11.41%
Feb 23, 2024
Maintains: Buy
Price Target: $242 → $268
Current: $1.11
Upside: +24,044.14%
Feb 9, 2024
Maintains: Neutral
Price Target: $450 → $505
Current: $828.32
Upside: -39.03%
Sep 21, 2017
Initiates: Neutral
Price Target: $57
Current: $0.90
Upside: +6,241.08%